期刊文献+

大疱性类天疱疮54例临床分析 被引量:11

Clinical analysis of 54 patients with bullous pemphigoid
暂未订购
导出
摘要 目的总结大疱性类天疱疮(bullous pemphigoid,BP)的临床特点和治疗经验。方法对54例BP住院患者的临床表现、实验室检查结果和临床疗效进行回顾性分析。结果中症BP患者糖皮质激素有效控制剂量(以泼尼松为标准量)为(1.08±0.41)mg/(kg.d),重症BP患者有效控制剂量为(1.48±0.34)mg/(kg.d),两者之间差异具有统计学意义(P<0.01)。结论系统使用糖皮质激素仍是目前治疗BP的首选疗法,可联合免疫抑制剂应用治疗BP。 Objective To summarize the clinical features and effective treatment for bullous pemphigoid.Methods To retrospectively analyze the clinical data of 54 cases with bullous pemphigoid from 2004 to 2009.Results The dose of corticosteroids in severe cases prednisone(1.48±0.34) mg/(kg·d) used to control lesions was much higher than that in moderate cases(1.08±0.41) mg/(kg·d)(P〈0.01).Conclusion Systemic corticosteroids were the major treatment for bullous pemphigoid,in combination with further immunosuppressive agents can help control disease activity sufficiently.
出处 《安徽医学》 2010年第6期577-579,共3页 Anhui Medical Journal
关键词 大疱性类天疱疮 糖皮质激素 免疫抑制剂 Bullous pemphigoid Corticosteroids Immunosuppressive agents
  • 相关文献

参考文献6

  • 1王娣,陈喜雪,朱学骏.124例大疱性类天疱疮治疗回顾[J].中华皮肤科杂志,2007,40(1):7-9. 被引量:32
  • 2Li L,Chen J,Wang B,et al.Sera from patients with bullous pemphigoid (BP) associated with neurological diseases recognized BP antigen 1 in the skin and brain.Br J Dermatol,2009,160(6):1343-1345.
  • 3Czernik A,Bystryn JC.Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents:marked improvement in depletion of circulating autoantibodies.Arch Dermatol,2008,144(5):658-661.
  • 4Bernard P,Reguiai Z,Tancrède-Bohin E,et al.Risk factors for relapse in patients with bullous pemphigoid in clinical remission:a multicenter,prospective,cohort study.Arch Dermatol,2009,145(5):537-542.
  • 5Joly P,Benichou J,Lok C,et al.Prediction of survival for patients with bullous pemphigoid:a prospective study.Arch Dermatol,2005,141(6):691-698.
  • 6郭绍兰,金始宇.恶性肿瘤合并大疱性类天疱疮6例报告[J].安徽医学,2005,26(5):455-455. 被引量:1

二级参考文献8

  • 1李丽,王宝玺.内脏肿瘤的皮肤表现[J].癌症进展,2004,2(1):46-50. 被引量:3
  • 2Wojnarowska F,Kirtschig G,Highet AS,et al.Guidelines for the management of bullous pemphigoid.Br J Dermatol,2002,147 (2):214-221.
  • 3Guillaume JC,Vaillant L,Bernard P,et al.Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid.Arch Dermatol,1993,129 (1):49-53.
  • 4Chosidow O,Saada V,Diquet B,et al.Correlation between the pretreatment number of blisters and the time to control bullous pemphigoid with prednisone 1 mg/kg/day.Br J Dermatol,1992,127(2):185-186.
  • 5Bara C,Maillard H,Briand N,et al.Methotrexate for bullous pemphigoid:preliminary study.Arch Dermatol,2003,139 (11):1506-1507.
  • 6Ratnam KV.Adjuvant therapy of bullous pemphigoid with mycophenolate mofetil:old drug,new use.Singapore Med J,2001,42(10):482-484.
  • 7杨卫兵.天疱疮的发病原因[J].国外医学(皮肤性病学分册),1998,24(3):140-143. 被引量:17
  • 8周小勇,李慧珠.大疱性类天疱疮89例临床分析[J].中华皮肤科杂志,2001,34(6):425-427. 被引量:17

共引文献31

同被引文献51

引证文献11

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部